Jonathan Swietlik

Jonathan Swietlik is a Senior Scientist in Proteomics at Odyssey Therapeutics since October 2022. Prior to this role, Jonathan completed a PhD in the Department of Proteomics and Signal Transduction at the Max Planck Institute for Biochemistry, focusing on the cross-talk between cancer and immune cells through mass spectrometry-based proteomics from April 2018 to October 2022. Jonathan also gained experience through a research internship at Evotec, where a Master's thesis centered on cell-selective proteomics using bioorthogonal amino acid labeling was conducted between June 2017 and March 2018. Additional experience includes a visiting student position at the University of Cambridge, investigating tumor pre-conditioning effects, and an internship in product management at Roche Diagnostics Europe. Jonathan holds a Master of Science in Biochemistry from the Technical University of Munich and a Bachelor of Science in Biochemistry from Leipzig University.